Overview
- The oversubscribed private placement is expected to close on or about Oct. 10, subject to customary conditions, according to the company.
- NANO Nuclear said the shares were priced at the market under Nasdaq rules, while some outlets reported a $47-per-share reference.
- Shares fell nearly 13% on Wednesday after the financing disclosure, with one report citing a 16.9% drop to $47.04 at the close.
- Proceeds are earmarked to advance KRONOS MMR development and regulatory work, continue other microreactor projects, pursue potential acquisitions, and support general corporate needs.
- Separately, the company announced a Chicagoland manufacturing and R&D hub backed by $6.8 million in REV Illinois incentives, a planned investment of over $12 million, and 50 new jobs in collaboration with the University of Illinois.